Linking glucose metabolism to arterial stiffness and blood pressure in non-diabetic adults: the mediating role of FGF21 - Report - MDSpire

Linking glucose metabolism to arterial stiffness and blood pressure in non-diabetic adults: the mediating role of FGF21

  • By

  • Katarina Zakic

  • Christa Meisinger

  • Jakob Linseisen

  • Dennis Freuer

  • July 14, 2026

Share

Associations Between Glucose Metabolism, Arterial Stiffness, and Blood Pressure

Overview

This study investigates the relationships between glucose metabolism markers and blood pressure in non-diabetic adults, focusing on the role of FGF21. Higher post-challenge glucose levels showed associations with blood pressure and vascular function, but these findings did not remain statistically significant after correction for multiple testing.

Background

This study explores how glucose levels may influence blood pressure and arterial stiffness in non-diabetic individuals, examining the role of FGF21 as a potential mediator.

Data Highlights

No significant numerical data was presented in the article, but associations were noted between glucose levels and blood pressure parameters.

Key Findings

  • Two-hour glucose levels were positively associated with systolic blood pressure (b2 = 2.23; P = 0.024).
  • Mean arterial pressure showed a positive association with two-hour glucose levels (b2 = 1.70; P = 0.042).
  • Diastolic blood pressure was positively associated with two-hour glucose levels (b2 = 1.48; P = 0.041).
  • Augmentation index (AIx) was positively associated with two-hour glucose levels (b2 = 0.96; P = 0.037).
  • No notable mediation effects of FGF21 were found in any of the associations.
  • Associations were particularly noted in non-obese individuals and participants younger than 40 years.

Clinical Implications

Further research is needed to clarify the role of glucose levels in non-diabetic populations.

Conclusion

The findings indicate associations between glucose metabolism and blood pressure in non-diabetic adults, but these associations require careful interpretation due to lack of statistical significance after correction.

Related Resources & Content

  1. European Journal of Preventive Cardiology, 2025 -- Arterial stiffness mediates insulin resistance-related risk of atherosclerotic cardiovascular disease: a real-life, prospective cohort study
  2. Frontiers in Endocrinology, 2026 -- Association of the Single-Point Insulin Sensitivity Estimator with Arterial Stiffness: A Cross-Sectional Analysis
  3. European Journal of Preventive Cardiology, 2025 -- Sex-specific associations between blood pressure in early midlife and arterial stiffness 27 years later: the Hordaland Health Study
  4. 2025 High Blood Pressure (BP) Guideline - Professional Heart Daily | American Heart Association
  5. European Journal of Preventive Cardiology — Addressing Aortic Stiffness: The Need for Gender-Sensitive Hypertension Treatment in Midlife
  6. Circulating fibroblast growth factor 21 is associated with blood pressure in the Chinese population: a community-based study
  7. 2025 High Blood Pressure (BP) Guideline - Professional Heart Daily | American Heart Association
  8. Frontiers | Metabolic score for insulin resistance and the incidence of cardiovascular disease: a meta-analysis of cohort studies

Original Source(s)

Related Content